S
Sapna
About Sapna
Data last updated:
Sapna has 7 years in corporate governance. Holds Company Secretary and Director roles. Currently with 1 company, including Apl Research Centre Limited and Aurozymes Limited. Formerly with 14 companies, such as Curateq Biologics Private Limited and Auroactive Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Aurigene Pharmaceutical Services Limited at ₹645 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurigene Pharmaceutical Services Limited U74999KA2019PLC127964 | Company Secretary | 22 Oct 2024 | 2019 | ₹645 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Curateq Biologics Private Limited U24110TG2020PTC140190 | Additional Director | 31 Mar 2021 | 2020 | ₹9.49 Cr (FY 2025) | Active |
 Auroactive Pharma Private Limited U24230TG2020PTC138313 | Additional Director | 28 Mar 2024 | 2020 | ₹37.55 Cr (FY 2025) | Active |
| Auro Peptides Limited U24232TG2012PLC078350 | Additional Director | 05 Mar 2020 | 2012 | ₹23.52 Cr (FY 2025) | Active |
| Apl Healthcare Limited U24239TG2006PLC052053 | Additional Director | 23 May 2019 | 2006 | ₹4,413 Cr (FY 2025) | Active |
| Eugia Steriles Private Limited U24239TG2020PTC141428 | Company Secretary | 21 Jun 2021 | 2020 | ₹4.37 Cr (FY 2025) | Active |
 Eugia Pharma Specialities Limited U24297TG2013PLC087048 | Director | 26 Aug 2019 | 2013 | ₹4,829 Cr (FY 2025) | Active |
| Auro Vaccines Private Limited U24297TG2021PTC156684 | Director | 08 Nov 2021 | 2021 | ₹11.82 Cr (FY 2025) | Active |
| Apitoria Pharma Private Limited U24298TG2017PTC121342 | Additional Director | 02 May 2019 | 2017 | ₹6,812 Cr (FY 2025) | Active |
| Apl Research Centre Limited U24116TG2006PLC051171 | Company Secretary | 23 May 2019 | 2006 | – | Amalgamated |
| Aurozymes Limited U24232TG2013PLC091383 | Director | 02 May 2019 | 2013 | – | Amalgamated |
| Auronext Pharma Private Limited U74999TG2009PTC109591 | Director | 23 May 2019 | 2009 | ₹75.8 Lakh (FY 2023) | Amalgamated |
| Mviyes Pharma Ventures Private Limited U74999TG2017PTC116265 | Director | 23 Oct 2020 | 2017 | ₹20.4 Lakh (FY 2023) | Amalgamated |
 Silicon Life Sciences Private Limited U85100TG2008PTC057669 | Director | 23 May 2019 | 2008 | ₹139 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sapna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sapna
Sapna has 7 years in corporate governance. Holds Company Secretary and Director roles. Currently with 1 company, including Apl Research Centre Limited and Aurozymes Limited. Formerly with 14 companies, such as Curateq Biologics Private Limited and Auroactive Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Aurigene Pharmaceutical Services Limited at ₹645 Cr (FY 2025).
Sapna is associated with 1 company as Company Secretary and Director, including Aurigene Pharmaceutical Services Limited (₹645 Cr).
Sapna has expertise in General Business, Healthcare.
Sapna has 7 years in corporate governance.
By reported revenue, the largest current company of Sapna is Aurigene Pharmaceutical Services Limited, with revenue of ₹645 Cr (FY 2025).
Sapna currently holds positions at 1 company: Aurigene Pharmaceutical Services Limited (₹645 Cr).